ciprofibrate has been researched along with Hypertriglyceridemia in 7 studies
Hypertriglyceridemia: A condition of elevated levels of TRIGLYCERIDES in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this work was to examine the effect of the PPARalpha agonist, ciprofibrate, on the CETP gene expression, in the presence and absence of apolipoprotein (apo) CIII induced hypertriglyceridemia, and its impact on the HDL metabolism." | 3.75 | Ciprofibrate increases cholesteryl ester transfer protein gene expression and the indirect reverse cholesterol transport to the liver. ( Berti, JA; Bighetti, EJ; Casquero, AC; Oliveira, HC; Patrício, PR, 2009) |
| "Ciprofibrate treatment (100 mg/day for 1 month) effected marked reductions in both total plasma LDL and apo B-100 levels (approximately 19% and approximately 23%, respectively)." | 1.29 | Ciprofibrate therapy normalises the atherogenic low-density lipoprotein subspecies profile in combined hyperlipidemia. ( Bruckert, E; Chapman, MJ; Dejager, S, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casanova, MA | 1 |
| Medeiros, F | 1 |
| Trindade, M | 1 |
| Cohen, C | 1 |
| Oigman, W | 1 |
| Neves, MF | 1 |
| Bighetti, EJ | 2 |
| Patrício, PR | 1 |
| Casquero, AC | 1 |
| Berti, JA | 1 |
| Oliveira, HC | 2 |
| Alberici, LC | 1 |
| de Faria, EC | 1 |
| Degaspari, GR | 1 |
| Souza, CT | 1 |
| Vercesi, AE | 1 |
| Bruckert, E | 1 |
| Dejager, S | 1 |
| Chapman, MJ | 1 |
| Shepherd, J | 1 |
| Nagyová, A | 1 |
| Raslová, K | 1 |
| Ginter, E | 1 |
| Zimetbaum, P | 1 |
| Frishman, WH | 1 |
| Kahn, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Alpha Linolenic Acid (ALA) Supplementation on Essential Fatty Acids Profile During Pregnancy Compared to Common Supplements and the Epigenetic Effect on the Newborn[NCT03040856] | 0 participants (Actual) | Interventional | 2022-02-01 | Withdrawn (stopped due to Problems executing the study) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for ciprofibrate and Hypertriglyceridemia
| Article | Year |
|---|---|
Mechanism of action of fibrates.
Topics: Apolipoproteins B; Bezafibrate; Clofibric Acid; Female; Fenofibrate; Fibric Acids; Gemfibrozil; Huma | 1993 |
Effects of gemfibrozil and other fibric acid derivatives on blood lipids and lipoproteins.
Topics: Bezafibrate; Cholesterol, HDL; Clofibric Acid; Diabetes Mellitus, Type 2; Fenofibrate; Fibric Acids; | 1991 |
2 trials available for ciprofibrate and Hypertriglyceridemia
| Article | Year |
|---|---|
Omega-3 fatty acids supplementation improves endothelial function and arterial stiffness in hypertensive patients with hypertriglyceridemia and high cardiovascular risk.
Topics: Adult; Cardiovascular Diseases; Endothelium, Vascular; Fatty Acids, Omega-3; Female; Fibric Acids; H | 2017 |
Oxidation resistance of LDL in hypertriglyceridaemic patients treated with ciprofibrate.
Topics: Clofibric Acid; Copper; Diet, Fat-Restricted; Fibric Acids; Humans; Hypertriglyceridemia; Hypolipide | 1998 |
3 other studies available for ciprofibrate and Hypertriglyceridemia
| Article | Year |
|---|---|
Ciprofibrate increases cholesteryl ester transfer protein gene expression and the indirect reverse cholesterol transport to the liver.
Topics: Animals; Apolipoprotein C-III; Biological Transport; Cholesterol; Cholesterol Ester Transfer Protein | 2009 |
Hypertriglyceridemia increases mitochondrial resting respiration and susceptibility to permeability transition.
Topics: Animals; Atractyloside; Cell Respiration; Clofibric Acid; Fibric Acids; Guanosine Diphosphate; Hyper | 2003 |
Ciprofibrate therapy normalises the atherogenic low-density lipoprotein subspecies profile in combined hyperlipidemia.
Topics: Adult; Apolipoprotein B-100; Apolipoproteins B; Clofibric Acid; Fibric Acids; Humans; Hypercholester | 1993 |